Grace Science LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
Safety and Efficacy of GS-100 Gene Therapy in Patients With NGLY1 Deficiency
Phase 1
Recruiting
- Conditions
- NGLY1 Deficiency
- Interventions
- Genetic: GS-100
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Grace Science, LLC
- Target Recruit Count
- 6
- Registration Number
- NCT06199531
- Locations
- 🇺🇸
Oakland Children's Hospital (UCSF Benioff), Oakland, California, United States
🇺🇸Columbia University Irving Medical Center, New York, New York, United States
🇺🇸Texas Children's Hospital (Baylor College of Medicine), Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath